492 related articles for article (PubMed ID: 9755001)
1. Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry.
Edwards MB; Ratnatunga CP; Dore CJ; Taylor KM
Eur J Cardiothorac Surg; 1998 Aug; 14(2):156-64. PubMed ID: 9755001
[TBL] [Abstract][Full Text] [Related]
2. Mechanical versus biological valve prosthesis for surgical aortic valve replacement in patients with infective endocarditis.
Kytö V; Ahtela E; Sipilä J; Rautava P; Gunn J
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):386-392. PubMed ID: 31121026
[TBL] [Abstract][Full Text] [Related]
3. Further experience with the "no-react" bioprosthesis in patients with active infective endocarditis: 11-year single center results in 402 patients.
Musci M; Amiri A; Siniawski H; Stein J; Weng Y; Hetzer R
Thorac Cardiovasc Surg; 2013 Aug; 61(5):398-408. PubMed ID: 23564537
[TBL] [Abstract][Full Text] [Related]
4. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis.
Delay D; Pellerin M; Carrier M; Marchand R; Auger P; Perrault LP; Hébert Y; Cartier R; Pagé P; Pelletier LC
Ann Thorac Surg; 2000 Oct; 70(4):1219-23. PubMed ID: 11081874
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
[TBL] [Abstract][Full Text] [Related]
6. Mid-term follow-up in patients with Biocor porcine bioprostheses.
Bottio T; Rizzoli G; Gerosa G; Thiene G; Casarotto D
Cardiovasc Surg; 2002 Jun; 10(3):238-44. PubMed ID: 12044432
[TBL] [Abstract][Full Text] [Related]
7. [The incidence of endocarditis caused by a prosthetic valve and its risk factors].
Lengyel M; Jánosi A; Arvay A
Orv Hetil; 1989 Apr; 130(15):765-72. PubMed ID: 2652031
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis.
Fedoruk LM; Jamieson WR; Ling H; Macnab JS; Germann E; Karim SS; Lichtenstein SV
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):326-33. PubMed ID: 19185146
[TBL] [Abstract][Full Text] [Related]
9. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
Mykén PS
J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
[TBL] [Abstract][Full Text] [Related]
10. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses.
Ratnatunga CP; Edwards MB; Dore CJ; Taylor KM
Ann Thorac Surg; 1998 Dec; 66(6):1940-7. PubMed ID: 9930473
[TBL] [Abstract][Full Text] [Related]
11. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.
Chiang YP; Chikwe J; Moskowitz AJ; Itagaki S; Adams DH; Egorova NN
JAMA; 2014 Oct; 312(13):1323-9. PubMed ID: 25268439
[TBL] [Abstract][Full Text] [Related]
12. Tricuspid valve replacement: bioprostheses are preferable.
Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
[TBL] [Abstract][Full Text] [Related]
13. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
14. In patients with severe active aortic valve endocarditis, is a stentless valve as good as the homograft?
Perrotta S; Lentini S
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):309-13. PubMed ID: 20525759
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatments for infective endocarditis involving valve annulus.
Ishikawa S; Kawasaki A; Neya K; Abe K; Suzuki H; Koizumi S; Shibuya H; Horikawa M; Ueda K
Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):378-81. PubMed ID: 20081746
[TBL] [Abstract][Full Text] [Related]
16. Aortic valve replacement for endocarditis: determinants of early and late outcome.
Langley SM; Alexiou C; Stafford HM; Dalrymple-Hay MJ; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 Sep; 9(5):697-704. PubMed ID: 11041187
[TBL] [Abstract][Full Text] [Related]
17. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis.
Sabik JF; Lytle BW; Blackstone EH; Marullo AG; Pettersson GB; Cosgrove DM
Ann Thorac Surg; 2002 Sep; 74(3):650-9; discussion 659. PubMed ID: 12238819
[TBL] [Abstract][Full Text] [Related]
18. Comparison between early and late prosthetic valve endocarditis: clinical characteristics and outcomes.
Nonaka M; Kusuhara T; An K; Nakatsuka D; Sekine Y; Iwakura A; Yamanaka K
J Heart Valve Dis; 2013 Jul; 22(4):567-74. PubMed ID: 24224422
[TBL] [Abstract][Full Text] [Related]
19. Redo aortic valve surgery: Influence of prosthetic valve endocarditis on outcomes.
Leontyev S; Borger MA; Modi P; Lehmann S; Seeburger J; Walther T; Mohr FW
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):99-105. PubMed ID: 20951390
[TBL] [Abstract][Full Text] [Related]
20. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up.
Georgiev S; Ewert P; Eicken A; Hager A; Hörer J; Cleuziou J; Meierhofer C; Tanase D
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008963. PubMed ID: 32600110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
